MAYO CLINIC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1889-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mayoclinic.org
A Study of Niacin Regulation
- First Posted Date
- 2023-12-18
- Last Posted Date
- 2024-06-10
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 32
- Registration Number
- NCT06175403
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Automating Delirium Severity in the ICU
Recruiting
- Conditions
- First Posted Date
- 2023-12-15
- Last Posted Date
- 2024-04-01
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 400
- Registration Number
- NCT06172491
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
A Study of a Lifestyle Program on Recurrent Atrial Fibrillation
Not Applicable
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2023-12-04
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 40
- Registration Number
- NCT06155357
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Neurotization of the Nipple Areolar Complex to Restore Sensation for Patients With Breast Cancer Undergoing Nipple Sparing Mastectomy and Reconstruction
- First Posted Date
- 2023-12-01
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 14
- Registration Number
- NCT06153836
- Locations
- 🇺🇸
Mayo Clinic in Florida, Jacksonville, Florida, United States
A Prospective Registry for Patients at High-Risk for Pancreatic Cancer
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-11-30
- Last Posted Date
- 2023-11-30
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 5000
- Registration Number
- NCT06151223
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study
- First Posted Date
- 2023-11-30
- Last Posted Date
- 2024-07-09
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 100
- Registration Number
- NCT06151730
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
A Comparative Clinical Study to Determine the Optimal Initial Therapy for Multiple Myeloma
- First Posted Date
- 2023-11-30
- Last Posted Date
- 2024-11-05
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 2370
- Registration Number
- NCT06151717
- Locations
- 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸Mayo Clinic in Florida, Jacksonville, Florida, United States
🇺🇸Mayo Clinic in Rochester, Rochester, Minnesota, United States
A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)
Phase 3
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-11-29
- Last Posted Date
- 2024-07-29
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 120
- Registration Number
- NCT06150560
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
A Study of Metabolic Agents Following Brain Radiation
- First Posted Date
- 2023-11-29
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 10
- Registration Number
- NCT06150547
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Remote Monitoring with Health-Coaching to Improve Quality of Life in Older Patients with Multiple Myeloma
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-11-24
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 25
- Registration Number
- NCT06145581
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
© Copyright 2024. All Rights Reserved by MedPath